Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder	Recruiting	Phase 1	2026-10-05		NCT07453602

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Arcutis Biotherapeutics, Inc.	4

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials